Q4 2025 13F Holders as of 31 Dec 2025
-
Type / Class
-
Equity / BIOTECHNOLOGY
-
Total 13F shares
-
1,073,570
-
Share change
-
+95,930
-
Total reported value
-
$88,198,598
-
Price per share
-
$82.15
-
Number of holders
-
109
-
Value change
-
+$7,978,985
-
Number of buys
-
43
-
Number of sells
-
34
Institutional Holders of INVESCO EXCHANGE TRADED FD T - BIOTECHNOLOGY (PBE) as of Q4 2025
As of 31 Dec 2025,
INVESCO EXCHANGE TRADED FD T - BIOTECHNOLOGY (PBE) was held by
109 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,073,570 shares.
The largest 10 holders included
MORGAN STANLEY, UNITED CAPITAL FINANCIAL ADVISORS, LLC, LPL Financial LLC, UBS Group AG, BANK OF AMERICA CORP /DE/, ROYAL BANK OF CANADA, WELLS FARGO & COMPANY/MN, Gerber Kawasaki Wealth & Investment Management, YHB Investment Advisors, Inc., and Cetera Investment Advisers.
This page lists
109
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.